Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Stina Linnea Wickström"'
Autor:
Andreas Lundqvist, Rolf Kiessling, Isabelle Magalhaes, Jonas Mattsson, Stefanie Renken, Takahiro Nakajima, Elias S J Arnér, Stina Linnea Wickström
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/887485c6314c4b53bae9b48c35e5c508
Autor:
Klas Kärre, Maria Helena Johansson, Ennio Carbone, Petter Höglund, Hanna Brauner, Tadepally Lakshmikanth, Sadia Salam, Rossana Tallerico, Stina Linnea Wickström, Arnika Kathleen Wagner
Supplementary Materials and Methods and Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32eeea84575a463fa5af31fac4e1f3fb
https://doi.org/10.1158/2326-6066.22537130
https://doi.org/10.1158/2326-6066.22537130
Autor:
Klas Kärre, Maria Helena Johansson, Ennio Carbone, Petter Höglund, Hanna Brauner, Tadepally Lakshmikanth, Sadia Salam, Rossana Tallerico, Stina Linnea Wickström, Arnika Kathleen Wagner
Supplementary Figure 2. Expresssion of MHC class I and activating receptor ligands on RMA and RMA-S.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c4b12a9d7379af83e7b4d033eb29703
https://doi.org/10.1158/2326-6066.22537142.v1
https://doi.org/10.1158/2326-6066.22537142.v1
Autor:
Klas Kärre, Maria Helena Johansson, Ennio Carbone, Petter Höglund, Hanna Brauner, Tadepally Lakshmikanth, Sadia Salam, Rossana Tallerico, Stina Linnea Wickström, Arnika Kathleen Wagner
Natural killer (NK) cells are most efficient if their targets do not express self MHC class I, because NK cells carry inhibitory receptors that interfere with activating their cytotoxic pathway. Clinicians have taken advantage of this by adoptively t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3bf6b7ad9abf3a7547d6cb3d1629af9
https://doi.org/10.1158/2326-6066.c.6548327.v1
https://doi.org/10.1158/2326-6066.c.6548327.v1
Autor:
Klas Kärre, Maria Helena Johansson, Ennio Carbone, Petter Höglund, Hanna Brauner, Tadepally Lakshmikanth, Sadia Salam, Rossana Tallerico, Stina Linnea Wickström, Arnika Kathleen Wagner
Supplementary Figure 1. Spleen cell number after inhibitory receptor blockade.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3301187b04e1bc739cf458806e60c49b
https://doi.org/10.1158/2326-6066.22537145.v1
https://doi.org/10.1158/2326-6066.22537145.v1
Autor:
Klas Kärre, Maria Helena Johansson, Ennio Carbone, Petter Höglund, Hanna Brauner, Tadepally Lakshmikanth, Sadia Salam, Rossana Tallerico, Stina Linnea Wickström, Arnika Kathleen Wagner
Supplementary Figure 3. In vivo receptor occupancy after monovalent 5E6 treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8894c35b7780f3aa94bfd9691a119e62
https://doi.org/10.1158/2326-6066.22537139
https://doi.org/10.1158/2326-6066.22537139
Autor:
Klas Kärre, Maria Helena Johansson, Ennio Carbone, Petter Höglund, Hanna Brauner, Tadepally Lakshmikanth, Sadia Salam, Rossana Tallerico, Stina Linnea Wickström, Arnika Kathleen Wagner
Supplementary Figure 4. Gating strategy used in responsiveness analysis (results shown in Figure 2).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::145a0d9f698fe0885c85f93f765259aa
https://doi.org/10.1158/2326-6066.22537136.v1
https://doi.org/10.1158/2326-6066.22537136.v1
Autor:
Stefanie Renken, Takahiro Nakajima, Isabelle Magalhaes, Jonas Mattsson, Andreas Lundqvist, Elias S J Arnér, Rolf Kiessling, Stina Linnea Wickström
Publikováno v:
Journal for immunotherapy of cancer. 10(6)
BackgroundAdoptive cell therapy using cytotoxic lymphocytes is an efficient immunotherapy against solid and hematological cancers. However, elevated levels of reactive oxygen species (ROS) in the hostile tumor microenvironment can impair NK cell and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328f0560b27d2437ec864fa09ecd93cf
https://pubmed.ncbi.nlm.nih.gov/35738800
https://pubmed.ncbi.nlm.nih.gov/35738800